XSACT 2.0: New software for X-ray scattering data processing and analysis
We are proud to present XSACT 2.0!, our all in-one solution for X-ray scattering data analysis.
Join DTI Webinar: why you should use X-rays in formulation of biologics
On December 10, 2020, 15.00-16.00 (CET), the Danish Technological Institute together with BioPeople will host a webinar with renowned Xenocs customers titled “Why you should use X-rays in formulation of biologics”
SAXS/WAXS results help elucidate structure-function relationships in foams
Foams – gas trapped in solids or liquids – are common materials, found all around us. Liquid foams can be found in cosmetic formulations, home care products and food, whereas solid foams find use in mattresses, insulation and lightweight structures in automotive, space and aircraft applications. Solid foams are cellular…
Xenocs SAXS webinars
Join our webinar!: Characterizing formulations, drug targets and viruses with Small Angle X-ray Scattering. October 27 / October 30, 2020.
Oléron 2020
9-16 October 2020, Oléron, France. 7th National School in Integrative Structural Biology.
Xenocs participates in Mobility Challenge for cleaner commuting
Xenocs will participate this year in the Mobility Challenge Day organized by the Auvergne-Rhône-Alpes Region, France, to promote ‘clean’ transport modes.
Different production process results in different gel properties in a surfactant based gel for pharmaceutical and cosmetics products
Different production process results in different gel properties in a surfactant based gel for pharmaceutical and cosmetics products.
Analysing polymer nanocomposites with X-ray scattering
- Application highlight - Nanocomposites are a type of composite material in which nanoscale particles or fibres (the filler) consisting of one or more materials are dispersed throughout a bulk (matrix) material. Both the filler(s) and the matrix retain elements of their own bulk material properties, while the nanoscale parameters…
White paper – SAXS for drug development and formulations
The global COVID-19 pandemic stresses the necessity to accelerate the different stages of drug development, reduce drug candidate attrition rates and establish solid testing protocols to ensure that only safe and stable formulations enter the market
Lab-based SEC-SAXS in combination with several other techniques elucidates the quaternary structure of PieE, an enzyme involved in antibiotic biosynthesis
Lab-based SEC-SAXS in combination with several other techniques elucidates the quaternary structure of PieE, an enzyme involved in antibiotic biosynthesis
